作者:Xing Zheng、Xu Yao、Yunmei Liu、Zitong Zheng、Jianguo Cao、Duanfang Liao
DOI:10.1007/s00044-009-9271-z
日期:2010.12
A series of genistein derivatives was prepared and tested in vitro against leukocythemia (HL-60), colorectal adenocarcinoma (HT-29), and human gastric adenocarcinoma (SGC-7901) cell lines. Among these derivatives, 4',5-di-n-octoxy-7-gem-difluoromethylenegenistein, 9f, had the strongest activity against HL-60, HT-29, and SGC-7901 cells.